LGALS8

Galectin-8 · O00214 · LGALS8 on Sugi Atlas →

32,105 patent compounds predicted against LGALS8, 19,731 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL701054 SCHEMBL701054 0.56 8/20
SCHEMBL661256 SCHEMBL661256 0.55 8/20
SCHEMBL661257 SCHEMBL661257 0.55 8/20
SCHEMBL264210 SCHEMBL264210 0.50 8/20
SCHEMBL176296 SCHEMBL176296 0.71 7/20
SCHEMBL564651 SCHEMBL564651 0.44 7/20
SCHEMBL897124 SCHEMBL897124 0.46 6/20
SCHEMBL229813 SCHEMBL229813 0.56 5/20
SCHEMBL1097983 SCHEMBL1097983 0.56 5/20
SCHEMBL979254 SCHEMBL979254 0.39 4/20
SCHEMBL280278 SCHEMBL280278 0.36 4/20
SCHEMBL154476 SCHEMBL154476 0.32 4/20
SCHEMBL423526 SCHEMBL423526 0.32 4/20
SCHEMBL411273 SCHEMBL411273 0.77 3/20
SCHEMBL411274 SCHEMBL411274 0.77 3/20
SCHEMBL411624 SCHEMBL411624 0.77 3/20
SCHEMBL411625 SCHEMBL411625 0.77 3/20
SCHEMBL736151 SCHEMBL736151 0.77 3/20
SCHEMBL416471 SCHEMBL416471 0.72 3/20
SCHEMBL754690 SCHEMBL754690 0.67 3/20

Clinical trials — most relevant to LGALS8 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes PHASE2UNKNOWN
A Phase 2 Extension of Study GCS-100-CS-4003 PHASE2WITHDRAWN
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease PHASE2COMPLETED
Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction PHASE2UNKNOWN
A Phase 2 Extension Study of Study GCS-100-CS-4002 PHASE2COMPLETED
Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia PHASE2COMPLETED
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA PHASE2COMPLETED
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients PHASE1COMPLETED
The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease nanNOT_YET_RECRUITING
Effect of Low-Glycemic Index Mediterranean Diet on AGEs nanCOMPLETED
A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies nanCOMPLETED
A Wearable Device and AI-Supported Diet and Exercise Intervention nanRECRUITING
Galectin and Respiratory Weaning nanUNKNOWN
Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring nanUNKNOWN
Urinary G3BP as a Novel Biomarker in Lupus Nephritis nanNOT_YET_RECRUITING
The Role of Galectins in the Non-invasive Diagnosis of Endometriosis nanUNKNOWN
Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure nanCOMPLETED
Galectin-3 as a Biomarker in Patients With Chagas Disease nanCOMPLETED
Galectin-3 in Septic and Non-septic Acute Kidney Injury nanUNKNOWN
Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter nanCOMPLETED
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage nanUNKNOWN
Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia nanUNKNOWN
Early Gestational Diabetes Screening in the Gravid Obese Woman nanCOMPLETED
Galectin-3 in Patients With Endometriosis nanUNKNOWN
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes nanCOMPLETED
Minimally Invasive Kidney Transplantation nanUNKNOWN
Biomarkers for Risk Stratification After STEMI nanUNKNOWN
Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients nanUNKNOWN
Biomarkers of Lichen Sclerosus nanUNKNOWN
Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LGALS8 binder may also engage these)

ProteinNameSimilarity
Q62665 1.000 Q62665 →
Q9JL15 0.997 Q9JL15 →
O54891 0.982 O54891 →
Q9UHV8 0.980 Q9UHV8 →
Q05315 0.978 Q05315 →
Q8TCE9 0.974 Q8TCE9 →
Q29058 0.972 Q29058 →
P07583 0.972 P07583 →
P11762 0.971 P11762 →
Q9Z144 0.970 Q9Z144 →
P97840 0.969 P97840 →
P47967 0.969 P47967 →
O08573 0.969 O08573 →
Q5R7M1 0.969 Q5R7M1 →
O44126 0.968 O44126 →
A8MUM7 0.968 A8MUM7 →
C0HJR3 0.968 C0HJR3 →
LGALS4 Galectin-4 0.967 landscape →
Q3MHZ8 0.966 Q3MHZ8 →
P36573 0.966 P36573 →
P38552 0.965 P38552 →
Q6DKI2 0.965 Q6DKI2 →
P16045 0.964 P16045 →
Q6DGJ1 0.963 Q6DGJ1 →
Q9CQW5 0.963 Q9CQW5 →
P97590 0.963 P97590 →
Q49I35 0.963 Q49I35 →
Q3B8N2 0.961 Q3B8N2 →
C0HJQ1 0.961 C0HJQ1 →
Q09581 0.961 Q09581 →